Benson Hill Biosystems nets $7.3 mln Series A

Missouri and North Carolina-based Benson Hill Biosystems, an agricultural solutions provider, has raised $7.3 million in Series A funding. Middleland Capital led the round with participation from Mercury Fund, Prelude Ventures, Prolog Ventures, Alexandria Venture Investments, Cultivation Capital, TechAccel, Missouri Technology Corporation and Biogenerator. In conjunction with the funding, Scott Horner of Middleland Capital and Dan Watkins of Mercury Fund have been added to Benson Hill’s board of directors.


Rally4 buys mGive

Rally4 said Tuesday that it has acquire mGive, which also received additional funding from Prolog Ventures. Financial terms weren’t announced. Denver-based mGive provides a mobile fundraising platform for nonprofit organizations.

VC-backed AirXpanders snags $7 mln from GE Capital

AirXpanders has received a $7 million credit facility from GE Capital. Based in Palo Alto, Calif., AirXpanders is a tissue-expansion company focused on breast cancer reconstruction. It is backed by Vivo Ventures, GBS Venture Partners, Prolog Ventures, Heron Capital and Shalon Ventures.

AirXpanders Secures Series D Round

AirXpanders, a company developing technology to address unmet needs for patients who require tissue expansion for breast reconstruction surgery, has secured $10 million in Series D financing. The round includes $7 million from new investor Vivo Ventures and $3 million from existing investors GBS Venture Partners, Prolog Ventures, Heron Capital and WTI. PRESS RELEASE AirXpanders […]

VC-Backed Nexus Dx Adds Nemmers to Board

San Diego-based Nexus Dx Inc. has named Joseph Nemmers Jr. to its board of directors. Nemmers is the principal in a private consulting practice specializing in the pharmaceutical and medical device industries, and serves as an advisor to Warburg Pincus . Nexus is backed by investors including Bay City Capital, Kleiner Perkins Caufield & Byers, Prolog Ventures and Warburg Pincus.

Medical Device Startup Veniti Lands $13.5 Million Series A

Veniti, a Saint Louis-based medical device company, has raised a $13.5 million Series A round led by Baird Venture Partners, H&Q Healthcare Investors, and H&Q Life Sciences Investors. Veniti develops devices for treating venous disease, including a stent system. Its first products are expected to be available later this year, according to the company. PRESS […]

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget